Reaction
Listeria Sepsis reporting signals
As of the last recalculation, Listeria Sepsis appears in 263 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 108.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 24 | 108.0 | 108.1 |
| Ampicillin | 9 | 89.0 | 89.1 |
| Ampicillin Sodium | 9 | 89.0 | 89.1 |
| Obinutuzumab | 16 | 81.9 | 82.0 |
| Bleomycin Sulfate | 6 | 47.0 | 47.0 |
| Daratumumab | 20 | 42.8 | 42.8 |
| Bendamustine Hydrochloride | 6 | 40.6 | 40.6 |
| Bendamustine Hcl | 7 | 36.7 | 36.7 |
| Carfilzomib | 8 | 23.1 | 23.1 |